Multidrug resistance mediated by overexpression of P-glycoprotein in human osteosarcoma in vivo

International Journal of Oncology

Volumn 12, Issue 2, 1998, Pages 287-291

  Suto, Ryuji ^a   Abe, Yoshiyuki ^a   Nakamura, Masato ^a   Ohnishi, Yasuyuki ^b   Yoshimura, Masumi ^b   Lee, Yoon Hwan ^a   Imanishi, Takashi ^a   Yamazaki, Hitoshi ^a   Kijima, Hiroshi ^a   Tokunaga, Tetsuji ^a   Oshika, Yoshiro ^a   Hiraoka, Nobuyoshi ^a   Tamaoki, Norikazu ^a   Fukuda, Hiroaki ^a   Ueyama, Yoshito ^a,b  

^a TOKAI UNIVERSITY   (Japan)

^b CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

Multidrug resistance; Osteosarcoma; P glycoprotein; Xenograft

Indexed keywords

CYCLOSPORIN A; DOXORUBICIN; GLYCOPROTEIN P; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRAFT; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; XENOGRAFT;

EID: 13144293033     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.2.287     Document Type: Article

References (28)

1. Winkler K, Beron G, Delling G, Heise U, Kabisch H, Purfurst C, Berger J, Ritter J, Jurgens H, Gerein V, Graf N, Russe W, Gruemayer ER, Ertelt W, Kotz R, Preusser P, Prindull G, Bradeis W and Landbeck G: Neoadjuvant chemotherapy of osteosarcoma: Results of a randomized co-operative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 6: 329-337, 1988.
2. Cassano WF, Graham-Pole J and Dickson N: Etoposide, cyclophosphamide, cisplatin and doxorubicin as neoadjuvant chemotherapy for osteosarcoma. Cancer 68: 1899-1902, 1991.
3. Classer DB, Lane JM, Huvos AG, Marcove RC and Rosen G: Survival, prognosis and. therapeutic response in osteogenic sarcoma. Cancer 69: 698-708, 1992.
4. Meyers PA, Heller G, Healey J, Huvos A, Lane J, Marcove R, Applewhite A, Vlamis V and Rosen G: Chemotherapy for nonmetastatic osteogenic sarcoma: The memorial Sloan-Kettering experience. J Clin Oncol 10:5-15, 1992.
5. Bacci G, Picci P, Ruggieri P, Mercuri M, Avella M, Capanna R, Branch Del Prever A, Mancini A, Gherlinzoni F, Padvani G, Leonessa C, Biagini R, Ferraro A, Ferruzzi A, Cazzola A, Manfrini M and Campanacci M: Primary chemotherapy and delayed surgery (neoajuvant chemotherapy) for osteosarcoma of the extremities. Cancer 65: 2539-2553, 1990.
6. Rosen G and Nirenberg A: Neoadjuvant chemotherapy for osteogenic sarcoma: A five year follow-up (T-10) and preliminary report of new studies (T-12). In: Primary Chemotherapy in Cancer Medicine. Alan R Liss Inc, New York pp39-51, 1985.
7. Chen C, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MN and Roninson IB: Internal duplication and homology with bacterial transport proteins in the MDRI (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47: 381-389, 1986.
8. Ueda K, Clark DP, Chen C, Roninson IB, Gottesman MM and Pastan I: The human multidrug resistance (MDRI) gene. J Biol Chem 262: 505-508, 1987.
9. Chen C, Clark D, Ueda K, Pastan I, Gottesman MM and Roninson IB: Genomic organization of the human multidrug resistance (MDRI) gene and origin of P-glycoproteins. J Biol Chem 265: 506-514, 1990.
10. Fojo AT, Whang-Peng J, Gottesman MM and Pastan I: Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 82: 7661-7665, 1985.
11. Gros P, Neriah YB, Croop JM and Hoouseman DE: Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 323: 728-731, 1986.
12. Imanishi T, Abe Y, Suto R, Higaki S, Ueyama Y, Nakamura M, Tamaoki N, Fukuda H and Imai N: Expression of the human multidrug resistance gene (MDRI) and prognostic correlation in human osteogenic sarcoma. Tokai J Exp Clin Med 19: 39-46, 1994.
13. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrius IL, Gazder AF, Willman CL, Griffith B, Von Hoff DD and Roninson IB: Quantitative analysis of MDRI (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87: 7160-7164, 1990.
14. Abe Y, Nakamura M, Ota E, Ozeki U, Tamai S, Inoue H, Ueyama Y, Ogata T and Tamaoki N: Expression of the multidrug resistance gene (MDRI) in non-small cell lung cancer. Jpn J Cancer Res 85: 536-541, 1994.
15. Abe Y, Yamazaki H, Oshika Y, Suto R, Tsugu A, Ota E, Satoh H, Ohshika Y, Yanagawa T, Ueyama Y, Tamaoki N and Nakamura M: Advantage of in vivo chemosensitivity assay to detect vincristine-resistance in a human epidermoid carcinoma xenograft. Anticancer Res 16: 729-734, 1996.
16. Toth K, Vaughan MN, Slocum HK, Arredondo MA, Takata H, Baker RM and Rustum YM: New immunohistochemical 'Sandwich' staining method for MDRI P-glycoprotein detection with JSB-1 monoclonal antibody in formalin-fixed, paraffin-embedded human tissues. Am J Pathol 144: 227-236, 1994.
17. Inaba M, Kobayashi T, Tashiro T, Sakurai Y, Maruo K, Ohnishi Y, Ueyama Y and Nomura T: Evaluation of antitumor activity in a human breast tumor/nude mouse model with a special emphasis on treatment dose. Cancer 64: 1577-1582, 1989.
18. Workman P, Balmain A, Hickman JA, McNally NJ, Mitchison NA, Pierepoint CG, Raymond R, Rowlatt C, Stephens TC and Wallace J: UKCCCR guidelines for the welfare of animals in experimental neoplasia. Br J Cancer 58: 109-113, 1988.
19. Abe Y, Nakamura M, Ohnishi Y, Inaba M, Ueyama Y and Tamaoki N: Multidrug resistance gene (MDRI) expression in human tumor xenografts. Int J Oncol 5: 1285-1292, 1994.
20. Abe Y, Nakamura M, Saegusa R, Ueyama Y, Ogata T and Tamaoki N: In vivo acquired drug resistance and multidrug resistance gene (MDRI) expression in the KB carcinoma cell line xenotransplanted in nude mice. Tokai J Exp Clin Med 18: 99-106, 1993.
21. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV and Deeley RG: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654, 1992.
22. Roninson IB, Pastan I, Gottesman MM: Isolation and characterization of the human MDR (P-glycoprotein) genes. In: Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells. Plenum, New York, pp91-104, 1991.
23. Starling JJ, Maciak RS, Hinson NA, Hoskins J, Laguzza BC, Gadski RA, Strnad J, Rittman-Grauer L, Deherdt SV, Bumol TF and Moore RE: In vivo selection of human tumor cells resistant to monoclonal antibody-vinka alkaloid immunoconjugates. Cancer Res 50: 7634-7640, 1990.
24. Abe Y, Ohnishi Y, Yoshimura M, Ota E, Ozeki Y, Oshika Y, Tokunaga T, Yamazaki H, Ueyama Y, Ogata T, Tamaoki N and Nakamura M: P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. Br J Cancer 74: 1929-1934, 1996.
25. Serra M, Scotlandi K, Manara MC, Maurici D, Benini S, Sarti M, Campanacci M and Baldini N: Analysis of P-glycoprotein expression in osteosarcoma. Eur J Cancer 31A: 1998-2002, 1995.
26. Scotlandi K, Serra M, Nicoletti G, Vaccari M, Manara MC, Nini G, Landuzzi L, Collaci A, Bacci G, Bertoni F, Picci P, Campanacci M and Baldini N: Multidrug resistance and malignancy in human osteosarcoma. Cancer Res 56: 2434-2439, 1996.
27. Serra M, Scotlandi K, Manara MC, Maurici D, Lollini PL, Giovanni CD, Toffoli G and Baldini N: Establishment and characterization of multidrug-resistant human osteosarcoma cell lines. Anticancer Res 13:323-330, 1993.
28. Houghton JA, Houghton PJ, Hazelton BJ and Douoglass EC: In situ selection of a human rhabdomyosarcoma resistant to vincristine with altered b-tublins. Cancer Res 45: 2706-2712, 1985.